Related Experiment Video
Updated: May 25, 2026

Intracranial Pharmacotherapy and Pain Assays in Rodents
Published on: April 9, 2019
Reduction of microemulsion propofol-induced injection pain via target-controlled remifentanil infusion
1Department of Anaesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, Republic of Korea.
Abstract:
The intravenous injection of microemulsion propofol to induce anaesthesia causes more intense and frequent pain than lipid emulsion propofol. This study investigated whether different target effect-site concentrations of remifentanil could prevent pain due to microemulsion propofol injection. In total, 96 patients were randomly assigned to one of three groups receiving target effect-site concentrations of remifentanil 0 (control group), 4 or 6 ng/ml, followed by injection with microemulsion propofol. Remifentanil pretreatment significantly reduced the incidence and severity of injection pain compared with the control group. Although no difference in pain reduction between the two remifentanil-treated groups was observed, those receiving a target effect-site concentration of 6 ng/ml exhibited an increased rate of complications, compared with those receiving 4 ng/ml. In conclusion, prior administration of remifentanil at a target effect-site concentration of 4 ng/ml is a useful strategy to decrease the injection pain of microemulsion propofol.
Insights
Remifentanil pretreatment effectively reduces pain from microemulsion propofol anesthesia injection. A target concentration of 4 ng/ml is recommended to minimize injection pain and complications.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Intravenous microemulsion propofol causes significant injection pain compared to lipid emulsion formulations.
- Managing propofol injection pain is crucial for patient comfort during anesthesia induction.
Purpose of the Study:
- To evaluate the efficacy of different target effect-site concentrations of remifentanil in preventing pain associated with microemulsion propofol injection.
- To determine the optimal remifentanil concentration for mitigating propofol injection pain.
Main Methods:
- A randomized controlled trial involving 96 patients undergoing anesthesia induction.
- Patients were assigned to receive remifentanil at target effect-site concentrations of 0 ng/ml (control), 4 ng/ml, or 6 ng/ml prior to microemulsion propofol administration.
Main Results:
- Remifentanil pretreatment significantly reduced both the incidence and severity of injection pain compared to the control group.
- No significant difference in pain reduction was observed between the 4 ng/ml and 6 ng/ml remifentanil groups.
- The 6 ng/ml remifentanil group showed a higher rate of complications than the 4 ng/ml group.
Conclusions:
- Pre-administration of remifentanil at a target effect-site concentration of 4 ng/ml is an effective strategy to decrease microemulsion propofol injection pain.
- A remifentanil concentration of 4 ng/ml appears to be a favorable balance between efficacy and safety for managing propofol injection pain.
Related Concept Videos
Parenteral Anesthetics: Overview
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Local Anesthetics: Clinical Application as Intravenous Regional Anesthesia
One of the advantages of...